Harrow to Present at Three Investor Conferences in September in New York

Rhea-AI Summary

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, has announced its participation in three investor conferences in New York this September. The events include:

• H.C. Wainwright 26th Annual Global Investment Conference (Sept 9-11, 2024)
• Lake Street 8th Annual Best Ideas Growth Conference (Sept 12, 2024)
• Cantor 2024 Global Healthcare Conference (Sept 17-19, 2024)

Harrow will present at the H.C. Wainwright conference on Sept 10 at 8:00 a.m. ET and host a Fireside Chat at the Cantor conference on Sept 18 at 2:30 p.m. ET. The company will conduct one-on-one meetings at all three events. Audio webcasts for the H.C. Wainwright and Cantor conferences will be available on Harrow's website.

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences in September in New York:

H.C. Wainwright 26^th Annual Global Investment Conference (Lotte New York Palace Hotel)
September 9-11, 2024
Company will present at 8:00 a.m. ET on September 10, 2024

Lake Street 8th Annual Best Ideas Growth Conference – Big 8 (The Yale Club)
September 12, 2024
1x1 Meetings Only

Cantor 2024 Global Healthcare Conference (InterContinental New York Barclay Hotel)
September 17-19, 2024
Company will host a Fireside Chat at 2:30 p.m. ET on September 18, 2024

The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. To listen to the audio webcast of either the H.C. Wainwright or Cantor conferences, please visit the Company’s website. The Lake Street conference will not be webcast.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240903179422/en/

Jamie Webb, Director of Communications and Investor Relations

jwebb@harrowinc.com

615-733-4737

Source: Harrow, Inc.

FAQ

What investor conferences is Harrow (HROW) attending in September 2024?

Harrow (HROW) is attending three investor conferences in New York in September 2024: H.C. Wainwright 26th Annual Global Investment Conference, Lake Street 8th Annual Best Ideas Growth Conference, and Cantor 2024 Global Healthcare Conference.

When is Harrow (HROW) presenting at the H.C. Wainwright conference?

Harrow (HROW) is presenting at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, at 8:00 a.m. ET.

Will Harrow (HROW) be conducting one-on-one meetings at these conferences?

Yes, Harrow (HROW) will be conducting one-on-one meetings at all three investor conferences in September 2024.

How can investors listen to Harrow's (HROW) presentations at these conferences?

Investors can listen to audio webcasts of Harrow's (HROW) presentations at the H.C. Wainwright and Cantor conferences on the company's website. The Lake Street conference will not be webcast.